Acrivon ipo price
WebNov 15, 2024 · After delaying its offering by a few days, the company sold 7,550,000 shares at $12.50 apiece. It also agreed to sell another 400,000 shares at the IPO price to its top … WebNov 15, 2024 · Acrivon Therapeutics (NASDAQ: ACRV) is a clinical-stage oncology company leveraging its precision medicine platform, Acrivon Predictive Precision Proteomics (AP3), for the development of its drug pipeline. Use the CB Insights Platform to explore Acrivon Therapeutics's full profile. ... Date of IPO 11/15/2024. Market Cap 0.40B. …
Acrivon ipo price
Did you know?
WebMar 26, 2024 · ACRV, a recent IPO, has a market cap of $273mn, a stock price of $13, and a cash reserve of $170mn. There are financial statements from September 2024 - here - where cash shown is some $77mn. WebOct 12, 2024 · Acrivon obtained rights to the drug in 2024 and is testing it in Phase 2 studies in ovarian, endometrial and bladder cancers. IPO research firm Renaissance Capital estimated the offering could raise up to $100 million, which, though only a preliminary estimate, would be a sizable IPO in a down year for new biotech stock offerings.
WebAcrivon Therapeutics, Inc. (ACRV) Stock Price, News, Quote & History - Yahoo Finance U.S. markets closed Acrivon Therapeutics, Inc. (ACRV) NasdaqGM - NasdaqGM Real … WebAcrivon Therapeutics secures $100M to give Eli Lilly cancer drug another try, fund 2 solid tumor candidates Boston Business Journal 11. 11. 2024 With $100M, startup to bring Lilly-licensed drug into trials Precision Oncology News 11. 11. 2024 Acrivon Therapeutics Raises $100M in Series B Funding See more
WebRenaissance Capital — Oncology biotech Acrivon Therapeutics prices IPO at $12.50, well below the range Find More Contacts for Acrivon Therapeutics Peter Blume-Jensen CEO, Founder, President Executive Management 1 email found View contacts for Acrivon Therapeutics to access new leads and connect with decision-makers. View All Contacts … WebNov 3, 2024 · Acrivon's IPO Details ACRV intends to sell 5.9 million shares of common stock at a proposed midpoint price of $17.00 per share for gross proceeds of …
WebNov 8, 2024 · The precision medicine company said in a filing that it plans to offer 5.9M shares priced between $16 and $18, which would raise around $100M if priced at the …
WebApr 12, 2024 · According to analysts' consensus price target of $21.00, Acrivon Therapeutics has a forecasted upside of 138.9% from its current price of $8.79. Amount of Analyst Coverage Acrivon Therapeutics has … local beatsWebNov 14, 2024 · Acrivon’s shares are expected to begin trading on the Nasdaq Global Market on November 15, 2024 under the ticker symbol “ACRV.” The offering is expected to close on November 17, 2024, subject to customary closing conditions. Jefferies, Cowen … indian bank jind ifsc codeWebNov 15, 2024 · In addition to the shares sold in the initial public offering, Acrivon announced a concurrent sale of 400,000 shares of common stock at the public offering price per … local beekeeper new smyrna beach flWebMar 17, 2024 · The latest price target for Acrivon Therapeutics ( NASDAQ: ACRV) was reported by Cowen & Co. on Monday, December 12, 2024. The analyst firm set a price target for 0.00 expecting ACRV to fall... indian bank jafferkhanpet ifsc codeWebAcrivon Therapeutics (ACRV) priced its IPO at $12.50 – far below its initial price range of $16.00 to $18.00 – and sold 7.55 million shares (7,550,000 shares) on Monday night … indian bank joint accountWebNov 15, 2024 · Acrivon Therapeutics, a Phase 2 biotech developing proteomics-based precision oncology therapies, raised $94 million by offering 7.6 million shares at $12.50, well below the range of $16 to $18. The company offered 1.7 million more shares than anticipated, and prior to pricing, it had disclosed insider indications on 88% of shares in … indian bank jolarpettai branch ifsc codeWeb27 rows · Business: ( Note: Acrivon Therapeutics priced its IPO on Monday night, Nov. 14, 2024, at $12.50 ... indian bank kiit branch ifsc code